T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes

Diabetes

Volumn 49, Issue 3, 2000, Pages 356-366

  Hawkes, Charlotte J ^a   Schloot, Nanette C ^b   Marks, Joanne ^a   Willemen, Sabine J M ^b   Drijfhout, Jan W ^b   Mayer, Erik K ^a   Christie, Michael R ^a   Roep, Bart O ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN;

ADOLESCENT; ANTIGEN SPECIFICITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE MAPPING; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034005833     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.3.356     Document Type: Article

References (53)

1. Bach J-F: Insulin-dependent diabetes as an autoimmune disease. Endocr Rev 14:516-542, 1994
2. Palmer J, Asplin C, Clemons P, Lyen K, Tapati O, Raghu P, Pauquette T: Insulin autoantibodies in insulin-dependent diabetes before insulin treatment. Science 222:1337-1338, 1982
3. Baekkeskov S, Aanstoot H, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P: Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
4. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo Y-LS, Martin S, Martin A, Powers AC, Prochada M, Naggert J, Leiter EH, Eisenbarth GS: Islet cell autoantigen 69kD (ICA 69): molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 92:359-371, 1993
5. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, Rae PMM: Islet antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152:3183-3188, 1994
6. Payton MA, Hawkes CJ, Christie MR: Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96:1506-1511, 1995
7. Lu J, Li Q, Xie H, Chen ZJ, Borovitskaya AE, Maclaren NK, Notkins AL, Lan MS: Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci U S A 93:2307-2311, 1996
8. Hawkes CJ, Wasmeier C, Christie MR, Hutton JC: Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes 45:1187-1192, 1996
9. Hatfield ECI, Hawkes CJ, Payton MA, Christie MR: Cross reactivity between IA-2 and phogrin/IA-2β in binding of autoantibodies in IDDM. Diabetologia 40:1327-1333, 1997
10. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale E: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310, 1994
11. Christie MR, Roll U, Payton MA, Hatfield ECI, Ziegler AG: Validity of screening for individuals at risk for type I diabetes by combined analysis of autoantibodies to recombinant proteins. Diabetes Care 20:965-970, 1997
12. Genovese S, Bonfanti R, Bazzigaluppi E, Lampasona V, Benazzi E, Bosi E, Chiumello G, Bonifacio E: Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 39:1223-1226, 1996
13. Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E: Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J Immunol 157:2707-2711, 1996
14. Zhang B, Lan MS, Notkins AL: Autoantibodies to IA-2 in IDDM location of major antigenic determinants. Diabetes 46:40-43, 1997
15. Roep BO, Kallan AA, Hazenbos W, Bruining GJ, Bailyes EM, Arden SD, Hutton JC, De Vries R: T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 337:1439-1441, 1991
16. Scheinin T, Maenpaa J, Kontiainen S: Immune responses to insulin and lymphocyte subclasses at diagnosis of insulin-dependent diabetes and one year later. Immunobiology 180:431-140, 1990
17. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF, Erlander MG, Tobin AJ, Maclaren NK: Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458-459, 1992
18. Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365-1369, 1993
19. Roep BO, Duinkerken G, Schreuder GM, Kolb H, de Vries RR, Martin S: HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol 26:1285-1289, 1996
20. Durinovic Bello I, Hummel M, Ziegler AG: Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45:795-800, 1996
21. Ellis TM, Schatz DA, Ottendorfer EW, Lan MS, Wasserfall C, Salisbury PJ, She J-X, Notkins AL, Maclaren NK Atkinson MA: The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes 47:566-569, 1998
22. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological typing in clinical practice including donor-recipient matching in cadaveric transplantations. Tissue Antigens 39:225-235, 1992
23. Olerup O, Aldener A, Fogdell A: HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers in 2 hours. Tissue Antigens 41:119-134, 1993
24. de Koster HS, Amons R, Benckhuijsen WE, Feijlbrief M, Schellekens GA, Drijfhout JW: The use of dedicated peptide libraries permits the discovery of high affinity binding peptides. J Immunol Methods 187:179-188, 1995
25. Kallan AA, Roep BO, Arden SD, Hutton JC, De Vries RRP: Beta-cell reactive T-cell clones from type 1 diabetes patients are not beta cell specific and recognize multiple antigens. J Autoimmun 8:877-899, 1995
26. Res PCM, Telgt D, van Laar JM, Oudkerk Pool M, Breedveld FC, De Vries RRP: High antigen reactivity in mononuclear cells from sites of chronic infection. Lancet 336:1406-1408, 1990
27. Petersen LD, Duinkerken G, Bruining GJ, van Lier RA, De Vries RR, Roep BO: Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus. J Autoimmun 9:731-737, 1996
28. Roep BO, Kallan AA, Duinkerken G, Arden SD, Hutton JC, Bruining GJ, De Vries R: T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM. Diabetes 44:278-283, 1995
29. Rudy G, Stone N, Harrison LC, Colman PG, McNair P, Brusic V, French MB, Honeyman MC, Tait B, Lew AM: Similar peptides from two β cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med 1:625-633, 1995
30. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK: Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 94:2125-2129, 1994
31. Schloot NC, Roep BO, Wegmann DR, Yu L, Eisenbarth GS: T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients, and control subjects. Diabetes 40:332-338, 1997
32. Geluk A, van Meijgaarden KE, Schloot NC, Drijfthout JW, Ottenhoff THM, Roep BO: HLA-DR binding analysis of peptides from islet antigens in IDDM. Diabetes 47:1594-1601, 1998
33. Hiemstra HS, van Veelen PA, Schloot NC, Geluk A, van Meijgaarden KE, Willemen SJM, Leunissen JAM, Benckhuijsen WE, Amons R, de Vries RRP, Roep BO, Drijfhout JW: Definition of natural T cell antigens with mimicry epitopes obtained from dedicated synthetic peptide libraries. J Immunol 161: 4078-4082, 1998
34. Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, Elbracht R, Schmitz G, Meinl E, Hummel M, Ziegler AG, Wank R, Schendel DJ: Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 99:2405-2415, 1997
35. Bach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM: High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J Autoimmun 10:375-386, 1997
36. Kawasaki E, Hutton JC, Eisenbarth GS: Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes. Biochem Biophys Research Comm 227:440-447, 1996
37. Cui L, Yu WP, DeAizpurua HJ, Schmidli RS, Pallen CJ: Cloning and characterization of islet cell antigen-related protein-tyrosine phosphatase (PTP), a novel receptor-like PTP and autoantigen in insulin-dependent diabetes. J Biol Chem 271:24817-24823, 1996
38. Honeyman MC, Stone NL, Harrison LC: T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential mimicry with rotavirus and other environmental agents. Mol Med 4:231-239, 1998
39. Kaufmann DL, Clare-Salzer M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993
40. Congia M, Patel S, Cope AP, de Virgiliis S, Sonderstrup G: T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from prepoinsulin and proinsulin. Proc Natl Acad Sci U S A 95:3833-3838, 1998
41. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA: T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183-187, 1990
42. Martin R, Jaraquemada D, Flerlage M, Richert J, Whitaker J, Long EO, McFarlin DE, McFarland HF: Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T-cell lines from multiple sclerosis patients and healthy individuals. J Immunol 145:540-548, 1990
43. Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, Hochberger M, Albert ED, Adorini L: Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest 91:616-628, 1993
44. Honeyman MC, Brusic V, Stone NL, Harrison LC: Neural network-based prediction of candidate T-cell epitopes. Nat Biotechnol 16:966-969, 1998
45. Balducci-Silano PL, Layrisse ZE: HLA-DP and susceptibility to insulin-dependent diabetes mellitus in an ethnically mixed population: associations with other HLA alleles. J Autoimmun 8:425-437, 1995
46. Erlich HA, Rotter JI, Chang JD, Shaw SJ, Raffel LJ, Klitz W, Bugawan TL, Zeidler A: Association of HLA-DPB1*0301 with IDDM in Mexican Americans. Diabetes 45:610-614, 1996
47. Hawke S, Matsuo H, Nicolle M, Malcherek G, Melms A, Willcox N: Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immuno-targeting. Immunol Today 17:307-311, 1996
48. Hiemstra HS, Duinkerken G, Benckhuizen WE, Amons R, De Vries RRP, Roep BO, Drijfhout JW: The identification of CD4+ T-cell epitopes with dedicated synthetic peptide libraries. Proc Natl Acad Sci U S A 94:10313-10318, 1997
49. Willcox N, Baggi F, Batocchi AP, Beeson D, Harcourt G, Hawke S, Jarobson L, Matsuo H, Moody AM, Nagvekar N, Nicolle M, Ong B, Pantic N, Newsom-Davis J, Vincent A: Approaches for studying the pathogenic T cells in autoimmune patients. Ann N Y Acad Sci 681:219-237, 1993
50. Zhang JW, Medaer R, Chin Y, van den Berg-Loonen E, Raus JCM: Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann Neurol 32:330-335, 1992
51. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA: Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179:973-984, 1994
52. Scholz C, Patton KT, Anderson DE, Freeman GJ, Hafler DA: Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J Immunol 160:1532-1538, 1998
53. Douglas Petersen LG, van der Keur M, de Vries RRP, Roep BO: Autoreactive and immunoregulatory T-cell subsets in insulin-dependent diabetes mellitus. Diabetologia 42:443-449, 1999